ATE353652T1 - Östroprogestatives antikonzeptionsmittel - Google Patents

Östroprogestatives antikonzeptionsmittel

Info

Publication number
ATE353652T1
ATE353652T1 AT03008979T AT03008979T ATE353652T1 AT E353652 T1 ATE353652 T1 AT E353652T1 AT 03008979 T AT03008979 T AT 03008979T AT 03008979 T AT03008979 T AT 03008979T AT E353652 T1 ATE353652 T1 AT E353652T1
Authority
AT
Austria
Prior art keywords
contraceptional
estroprogestative
estroprogestative contraceptional
Prior art date
Application number
AT03008979T
Other languages
English (en)
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE353652(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of ATE353652T1 publication Critical patent/ATE353652T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT03008979T 1996-10-08 1997-10-08 Östroprogestatives antikonzeptionsmittel ATE353652T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation

Publications (1)

Publication Number Publication Date
ATE353652T1 true ATE353652T1 (de) 2007-03-15

Family

ID=9496456

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03008979T ATE353652T1 (de) 1996-10-08 1997-10-08 Östroprogestatives antikonzeptionsmittel
AT97944940T ATE238057T1 (de) 1996-10-08 1997-10-08 Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97944940T ATE238057T1 (de) 1996-10-08 1997-10-08 Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält

Country Status (38)

Country Link
US (4) US6831073B1 (de)
EP (2) EP0956022B1 (de)
JP (1) JP4883542B2 (de)
KR (2) KR20000048981A (de)
CN (3) CN101229173A (de)
AP (1) AP1171A (de)
AR (2) AR009113A1 (de)
AT (2) ATE353652T1 (de)
AU (1) AU745571B2 (de)
BR (1) BR9712274A (de)
CA (1) CA2268358C (de)
CL (1) CL2011000017A1 (de)
CZ (1) CZ298402B6 (de)
DE (3) DE69737373T2 (de)
DK (2) DK0956022T3 (de)
DZ (1) DZ2327A1 (de)
ES (2) ES2198006T3 (de)
FR (2) FR2754179B1 (de)
HK (1) HK1210708A1 (de)
HU (2) HU227450B1 (de)
ID (1) ID21569A (de)
IL (1) IL129194A (de)
LU (1) LU91932I2 (de)
MA (1) MA24370A1 (de)
MY (1) MY128482A (de)
NO (3) NO324357B1 (de)
NZ (1) NZ334876A (de)
OA (1) OA11033A (de)
PL (1) PL192979B1 (de)
PT (2) PT1334725E (de)
RU (1) RU2274450C2 (de)
SK (2) SK285056B6 (de)
TN (1) TNSN97164A1 (de)
TR (1) TR199900764T2 (de)
TW (1) TW491704B (de)
WO (1) WO1998015279A1 (de)
YU (1) YU18099A (de)
ZA (1) ZA979011B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
GT200500315A (es) * 2004-11-02 2006-06-06 Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
AR065816A1 (es) 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
RU2332219C1 (ru) * 2007-03-30 2008-08-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2021229559A2 (en) 2020-10-16 2021-11-18 Theramex HQ UK Limited Use of combined oral contraceptives containing nomegestrol acetate and estradiol
KR102744791B1 (ko) 2022-07-05 2024-12-19 주식회사 이음정보 소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
US5208225A (en) 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5256421A (en) 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
FI101601B (fi) * 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
AU2926897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
AU2926797A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041872A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU2926997A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1998004246A2 (en) 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
AU713016B2 (en) 1996-07-26 1999-11-18 Wyeth Oral contraceptive
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
AU3961697A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
KR20000029536A (ko) 1996-07-26 2000-05-25 이곤 이 버그 2상피임방법및프로제스틴과에스트로젠과의배합물을포함하는킷
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
PT1007052E (pt) 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc Combinacoes de progestinas de crescimento do endometrico e progestinas de atropia do endometrio com estrogenios, em contracepcao oral
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CA2301162A1 (en) 1997-09-12 1999-03-25 Michael Jay Gast Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
AP1171A (en) 2003-06-30
CZ9901120A3 (cs) 2000-11-15
ES2198006T3 (es) 2004-01-16
PL332610A1 (en) 1999-09-27
TR199900764T2 (xx) 1999-07-21
FR12C0005I1 (fr) 2012-02-24
AU745571B2 (en) 2002-03-21
TW491704B (en) 2002-06-21
NZ334876A (en) 2001-06-29
BR9712274A (pt) 1999-08-31
JP4883542B2 (ja) 2012-02-22
HUS1200002I1 (hu) 2016-08-29
DZ2327A1 (fr) 2002-12-28
ID21569A (id) 1999-06-24
EP0956022B1 (de) 2003-04-23
NO324357B1 (no) 2007-10-01
IL129194A0 (en) 2000-02-17
DE69721314D1 (de) 2003-05-28
MY128482A (en) 2007-02-28
JP2002509524A (ja) 2002-03-26
KR20060084864A (ko) 2006-07-25
NO991593D0 (no) 1999-03-31
CA2268358A1 (fr) 1998-04-16
SK43899A3 (en) 1999-12-10
CN1239893A (zh) 1999-12-29
PT1334725E (pt) 2007-05-31
DK1334725T3 (da) 2007-06-11
FR12C0005I2 (fr) 2016-06-24
NO2017043I1 (no) 2017-08-08
HUP9904508A2 (hu) 2000-06-28
PL192979B1 (pl) 2006-12-29
EP0956022A1 (de) 1999-11-17
ES2282539T3 (es) 2007-10-16
CL2011000017A1 (es) 2011-06-24
CN101229173A (zh) 2008-07-30
US6906049B1 (en) 2005-06-14
RU2274450C2 (ru) 2006-04-20
DE69737373T2 (de) 2007-06-21
US7749987B2 (en) 2010-07-06
DE69737373D1 (de) 2007-03-29
AR073972A2 (es) 2010-12-15
PT956022E (pt) 2003-07-31
DE69721314T2 (de) 2004-02-12
ZA979011B (en) 1998-06-03
NO2012002I1 (no) 2012-01-24
NO991593L (no) 1999-06-07
KR20000048981A (ko) 2000-07-25
CZ298402B6 (cs) 2007-09-19
DE122012000010I1 (de) 2012-04-19
US20070281912A1 (en) 2007-12-06
YU18099A (sh) 2002-03-18
OA11033A (fr) 2003-03-06
AP9901500A0 (en) 1999-06-30
ATE238057T1 (de) 2003-05-15
CA2268358C (fr) 2010-04-20
DK0956022T3 (da) 2003-08-04
NO2012002I2 (no) 2013-04-02
MA24370A1 (fr) 1998-07-01
US6831073B1 (en) 2004-12-14
LU91932I9 (de) 2018-12-27
EP1334725A3 (de) 2004-01-21
AR009113A1 (es) 2000-03-08
AU4627397A (en) 1998-05-05
NO2017043I2 (no) 2019-01-25
KR100782638B1 (ko) 2007-12-06
TNSN97164A1 (fr) 1999-12-31
SK285056B6 (sk) 2006-05-04
HUP9904508A3 (en) 2001-01-29
US20040220163A1 (en) 2004-11-04
SK285455B6 (sk) 2007-01-04
EP1334725A2 (de) 2003-08-13
IL129194A (en) 2003-06-24
HU227450B1 (en) 2011-06-28
LU91932I2 (fr) 2012-03-13
HK1210708A1 (en) 2016-05-06
EP1334725B1 (de) 2007-02-14
FR2754179B1 (fr) 1998-12-24
FR2754179A1 (fr) 1998-04-10
WO1998015279A1 (fr) 1998-04-16
CN104706641A (zh) 2015-06-17

Similar Documents

Publication Publication Date Title
DE69736781D1 (de) Implantierungsinstrument
DE69725646D1 (de) Spreizspektrumnachrichtenübertragungssystem
DE69727412D1 (de) Spreizspektrumnachrichtenübertragungsempfänger
NO990247D0 (no) Thiolsulfonamidmetalloproteaseinhibitorer
DE69737638D1 (de) Giesstauschrohr
DE69729325D1 (de) Mehrzweckuhr
DE69726807D1 (de) Chromatographieventilsatz
DE59712174D1 (de) Spickeln
DE69737314D1 (de) Netzeinschaltvorrichtung
DE69716372D1 (de) Endotoxinenadsorptionssystem
DE69713891D1 (de) Polymerentgasung
FI961556A0 (fi) Luftavskiljare
DE69736653D1 (de) Farbbildabtastgerät
FI964378A0 (fi) Torkapparat foer fiberbana
DE59707393D1 (de) Flüssigkeitsauspressgerät
DE69710847D1 (de) Beta-Hydroxyasparaginsäurederivate
FI962245A0 (fi) Planteringslaoda
FI2454U1 (fi) Kasviteline
FI2614U1 (fi) Parvekelasitusrakenne
FI102942B1 (fi) Saunan lauteet
FR2762976B1 (fr) Bigoudi
FI963092A0 (fi) Cylinderlaos
FI964036A0 (fi) Stoedanordning
FI964454A0 (fi) Uppkopplingsmatris
FI963487A0 (fi) Pyramidleksak

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1334725

Country of ref document: EP